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http:WHAT THIS PAPER ADDS
This study shows that the prevalence of chronic venous disease (CVD) is high, is currently underestimated and
that prevalence increases with age. Risk factors and symptomatology were evaluated. CVD results in impaired
quality of life and losses in productivity. Awareness of this disease must be improved among patients, healthcare
professionals, and authorities.Objective: This epidemiological study measured the prevalence of chronic venous disease (CVD) in Belgium and
Luxembourg. Possible risk factors and the symptomatology were evaluated.
Material and methods: A survey was carried out in Belgium and Luxembourg between May and September 2013.
Patient recruitment was carried out by 406 general practitioners (GPs). Each GP screened 10e20 consecutive
patients older than 18 years, and in total 6009 patients were included. Patient characteristics, prevalence of risk
factors, symptomatology, and C-classiﬁcation were noted. The GPs diagnosed CVD and measured the need for
treatment. Patients with diagnosed CVD completed a questionnaire about their history of leg problems and a
quality of life score (CIVIQ-14). These data were converted into a CIVIQ Global Index Score (GIS).
Results: The mean age of the patients was 53.4 years, and they were predominantly female (67.5%). Among the
3889 symptomatic patients, heavy legs, pain, and sensation of leg swelling were the most common complaints.
Among the included patients, 61.3% of patients were classiﬁed within C1-C6; however, only 45.9% of these
patients were considered by the GPs to be suffering CVD. Treatment was offered to 49.5% of patients. Age and
female gender correlate with a higher C-class (p < .001). Patients with a higher C-class (C3-C6) have signiﬁcantly
more pain, sensation of swelling and burning, night cramps, itching, and the sensation of “pins and needles” in
the legs.
Patients taking regular exercise and without a family history had a lower C-class. Higher BMI, age, female gender,
family history, history of thrombophlebitis, and a higher C-class correlated with a lower GIS (p < .001). Of the
patients with CVD, 10.4% had lost days of work because of their venous leg problems.
Conclusion: CVD is a very common disease, which is underestimated. The prevalence increases with age,
generates incapacity to work, and worsens the patients’ quality of life.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Chronic venous disease (CVD) is one of the most common
disorders in northern and western Europe.1e4 Estimates of
its prevalence vary based on population, selection criteria,
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//dx.doi.org/10.1016/j.ejvs.2014.12.031prevalence has been shown to increase with age.1e3 In a
population based study (Bonn Vein Study5,6), classiﬁcation
levels (CEAP-classiﬁcation) were 59.0% C1, 14.3% C2, 13.5%
C3, 2.9% C4, and 0.7% C5-C6. The estimated prevalence in
the UK adult population ranges from 20% to 40%.7 The age
stratiﬁed prevalence of truncal varicose veins measured in
the Edinburgh Vein study was 11.5% in the 18e24 age
group, increasing to 55.7% in the 55e64 age group.2,8
The etiology of varicose veins remains unclear,3 but is
likely to be multifactorial and includes, although un-
proven,1,9 a moderate to strong genetic component.10 Valve
damage and abnormal elastic properties, leading to
Table 1. Patient characteristics and risk factors.
Age 53.4 (17.6)
Gender
Female 67.5%
Male 32.5%
BMI 26.08  5.25
Occupation
Full time 40.2%
Part time 9.3%
Unemployed 3.9%
Student 3.4%
Retired 37.4%
Other 5.8%
Risk factors
Family history of venous leg
problems
46.4%
History of blood clots in the veins 16.5%
Number of hours per day standing 5.7  3.2
Number of hours per day sitting 5.9  2.9
Regular exercise taken 52.3%
Number of hours a day 6.4  7.5
Smoker (current or former) 41.6%
Among women
Number of births
0 17%
1 22.1%
2 35.1%
3 5.1%
4 5.7%
5 or more 3.1%
Currently taking birth control
pills
26.6%
Chronic Venous Disease in Belgium and Luxembourg 433increased venous pressure and distention, are the most
common etiology for primary varicose veins.11,12
Risk factors include high intravenous pressure (caused by
standing for long periods), sedentary lifestyle, pregnancy,
gender, and family history. Obesity itself is usually not
considered a risk factor; however, obese people with vari-
cose veins have more symptoms13 and a higher complica-
tion rate.1 Smoking in men has also been shown to be a risk
factor.14 Previous deep vein thrombosis (DVT) is the most
frequent cause of secondary varicose veins.3,11
In an attempt to provide a better understanding of the
worldwide prevalence of CVD in general practice and thus
to improve the awareness of this chronic disease among
patients, healthcare professionals, and authorities, a global
initiative has been launched: the Vein Consult Program
(VCP). This international, observational, prospective epide-
miological survey is carried out under the auspices of the
Union Internationale de Phlébologie (UIP). The VCP is the
largest worldwide CVD detection program ever undertaken
and it has been conducted in many countries.15e19 It col-
lects epidemiological data on the prevalence of CVD
symptoms, signs, CEAP classes, quality of life, and costs.
The protocol used is identical for all countries, including
the use of the C clinical classiﬁcation. This ensures that the
data collected on reporting, diagnosis, and treatment of
CVD are consistent and can be compared worldwide.
The present study details the results from the VCP for
Belgium and Luxembourg, and additional analysis has been
carried out with regard to risk factors and symptoms.Number of pregnant women 3.3%
Menopause 63.7%
Use of hormonal
replacement therapy
12.2%
C-classiﬁcation
C0w (asymptomatic) 24.8%, n ¼ 1425/5740
(valid answers)
C0s (symptomatic) 13.9%, n ¼ 796
C1 18.7%, n ¼ 1072
C2 16.7%, n ¼ 960
C3 13.7%, n ¼ 784
C4 9.2%, n ¼ 530
C5 2.1%, n ¼ 122
C6 0.9%, n ¼ 51MATERIALS AND METHODS
Patients were recruited by 406 selected GPs (general
practitioners) between May 1, and September 15, 2013.
GPs were selected in compliance with national regulations,
usually at random from a national registration list. Each
investigator included 10e20 consecutive patients who
attended the practice for various reasons. The minimum age
was 18 years. Patients attending for emergency visits were
excluded. Informed consent was obtained from each
participant. First, the patient was interviewed by the GP:
information regarding age, gender, height, occupation, body
mass index (BMI) as possible risk factors, was collected
using a questionnaire (consultation records form). These
possible risk factors include family history of CVD, personal
history of blood clots in leg veins, hours spent standing and
sitting, number of hours of exercise daily, and smoking.
Among women the number of births, current pregnancy,
and use of birth control pills and hormonal replacement
therapy was recorded. The GP asked the patients about the
presence of symptoms of CVD (heavy legs, pain in the legs,
sensation of swelling or burning, night cramps, itching,
sensation of pins and needles) and possible signs of CVD
(current problems with swollen legs, spider veins, varicose
veins, or ankle ulcers). Current or past medical treatment
for leg problems was also recorded.
Second, the GP scored the patients according to the C-
classiﬁcation by visual examination. The GPs received anillustrated guide on the C-classiﬁcation to ensure they
adequately reported the C-class of each patient in the case
report form. Diagnoses of CVD in patients were made by
the GP. No ultrasound examination was done. Patients
diagnosed with CVD ﬁlled in an additional quality of life
(QoL) questionnaire (CIVIQ-14). CIVIQ-14 is a reliable, valid,
and sensitive instrument applicable to international studies
of patients with chronic venous disease.20,21 The results
from the QoL questionnaire were transformed into a Global
Index Score (GIS, the difference between the ﬁnal score and
the minimum possible score, divided by the difference be-
tween the theoretical maximum and minimum scores,
multiplied by 100). The score ranges from 0 (worst QoL) to
100 (best QoL). Any history of previous treatment and
consequential incapacity to work was also noted.
Table 2. Prevalence of CVD symptoms.
Symptoms
(64.7% of
total patient
group)
Among these
symptomatic
patients: number
currently with:
Most common
symptom
Heavy legs 70.4%
Pain in the legs 54.0%
Sensation of
swelling
52.7%
Sensation of
burning
19.2%
Night cramps 46.5%
Itching 18.5%
Sensation of
pins and needles
23.8%
Number of symptoms
currently present
0 35.1%
1 16.5%
2 15.0%
3 12.8%
>3 20.6%
Current consultation
for problems with
leg veins
15.2%
434 M.E. Vuylsteke et al.The survey was approved by the ethics committee of the
University Hospital of Brussels (UZ Brussels) and the ethics
committee of Luxembourg (CNER).
Statistical analysis
The Proc freq SAS procedure with Cochran-Mantel-Haenszel
(CMH) statistics was used for data analysis. To compare
continuous and ordinal outcomes between groups, Mann-
Whitney U tests were applied (SPSS version 22). To inves-
tigate the relationship between CEAP classiﬁcation and
symptoms as to the inﬂuence of risk factors on the severity
of CVD, corrected for age and gender, a logistic regression
was performed. A Spearman test was used to calculate
possible correlations. For all tests, a p value <.05 was
considered to be statistically signiﬁcant.Figure 1. Age relaRESULTS
6009 patients were included in the survey. The mean age
was 53.4 (17.6) years, with 67.5% female. The average
BMI was 26.08 (5.25) with no statistical gender difference.
According to clinical examination by the GP, 61.3% (C1-
C6) and 75.2% (C0s-C6) of the patients had chronic
venous disease and 25.9% of the patients had chronic
venous insufﬁciency (CVI) (C3-C6) (Table 1). There was an
active ulcer in 0.9% of patients. In 15.2% of the patients, the
current consultation was performed for leg vein problems.
When the GP was asked whether the patient had CVD, a
positive answer was given in only 45.9% of cases, meaning
that the prevalence of CVD was underestimated.
64.7% of the patients had symptoms of CVD, with heavy
legs, pain, sensation of swelling, and night cramps being the
most frequent symptoms, which were obvious in the eve-
nings or after prolonged standing (Table 2). Among symp-
tomatic patients, 20.6% had more than three different
symptoms. 46.4% of patients had a positive family history of
CVD (most common risk factor).
According to the GPs, 49.5% of the total patient group
needed treatment for their CVD. These treatments were, in
order of decreasing frequency: lifestyle advice, venoactive
drugs, compression therapy, invasive treatment (sclero-
therapy, endovenous ablation, and surgery), and anti-
coagulation. Only 11% of patients were referred to a venous
specialist, while 6.5% were already under specialist care.
Based on a Mann-Whitney U test, the C-classiﬁcation was
signiﬁcantly higher for females than for males (p < .001).
Furthermore, a signiﬁcant positive Spearman correlation
(p < .001 in both groups) was observed between age and C-
class for women (Spearman correlation ¼ 0.42) and men
(Spearman correlation ¼ 0.41) (Fig. 1).
Both gender and age were signiﬁcantly related to C-class,
so additional logistic regression testing was used to correct
for that inﬂuence when testing the effect of risk factors for
a higher C-class. Among women, but only in the 18e34 age
group, patients taking birth control pills had a signiﬁcantlyted to C-class.
Chronic Venous Disease in Belgium and Luxembourg 435lower C-class compared with females not taking them
(p ¼ .022) (Fig. 2). A weak (positive) but signiﬁcant corre-
lation was identiﬁed between number of pregnancies and
C-class, which existed in each of the age groups. Also, a
signiﬁcant positive correlation was found between BMI and
the severity of CVD (C-classiﬁcation) for all age groups and
both genders (Fig. 3).
For all age groups and for both genders, C-class was
signiﬁcantly higher (p < .05 or less) for the “no regular
exercise” group compared with the “regular exercise
group”. It was only for males aged between 18 and 34 that
no signiﬁcant effect was found (p ¼ .054; however, the
results point in the same direction, Fig. 4). Also, the most
common risk factor, a positive family history of CVD, cor-
relates with a higher C-class for both age groups and gen-
ders (p < .001, Fig. 5).
Of the whole patient population, 41.6% were smokers
(current or past), and based on a Mann-Whitney U test,
patients with that risk factor had a signiﬁcantly higher C
class compared with non-smokers (Fig. 6).
The number of symptoms correlates with a higher C class
(Table 3), especially for grades C3-C6 (compared with C0s-
C2). Logistic regression using C class C3-C6 as a binary
predictor and correcting for age, gender, and signiﬁcant
interaction between these was performed. Patients with a
higher C classiﬁcation (C3-C6) have signiﬁcantly more pain
in the legs (p < .001), and a signiﬁcantly higher probability
of reporting heavy legs (p < .001), a sensation of swelling
(p < .001) and burning (p < .001), compared with the
group with C-classiﬁcation <3.
An association was also found between a higher C-class
(C3-C6) and experiencing night cramps (p < .001), itching
(p < .001), and having the sensation of pins and needles
(p < .001).
Patients with a positive diagnosis of CVD were asked to
ﬁll in a quality of life questionnaire (CIVIQ-14). These data
were recalculated into a GIS (0e100). GIS is not approxi-
mately normally distributed. Non-parametric methods wereFigure 2. Correlation between intakeused. A total of 3432 valid answers were obtained and the
median score in the total population was 86 (mean
80.59  19.26). Male patients had a signiﬁcantly better GIS
compared with female patients (median 94 vs. 84,
p < .001). In both females and males, age was negatively
correlated with GIS (p < .001). Mann-Whitney U tests and
Spearman correlations were calculated separately for each
age group and by gender. In all age groups and for both
genders, GIS are signiﬁcantly lower for the patients with a
positive family history, patients with a history of thrombo-
phlebitis, and patients with a higher BMI compared with
patients without these risk factors (p < .001).
A signiﬁcant negative correlation was found between C-
classiﬁcation and GIS for both genders in all age groups.
Higher C-classes are signiﬁcantly associated with lower GIS
(Table 4, p < .001).
Another signiﬁcant negative correlation was found be-
tween the number of symptoms and the QoL (GIS)
(p < .001).
Among those patients with a diagnosis of CVD, 2.1% had
made changes to their professional activities because of
venous leg problems. In 9.4% of cases, hospitalization was
necessary because of venous leg problems. Of these pa-
tients (positive CVD), 10.4% reported a loss of working days,
with these losses being less than 1 week (37.8%), between
1 week and 1 month (30.2%), and more than 1 month
(17.2%) (with 14.8% unknown).
DISCUSSION
The Vein Consult Program (VCP) has been carried out in
many countries.15e19 The advantage of the VCP is that the
same protocol has been used in each participating country,
which makes it possible to compare the results. In this
survey, however, more statistical analysis was added con-
cerning symptomatology and risk factors. Possible correla-
tions between these risk factors and the severity of CVD
(CEAP classiﬁcation) were examined. Any possible associa-
tion with QoL (GIS) was also assessed.of birth control pills and C-class.
Figure 3. Correlation between BMI and C-class.
436 M.E. Vuylsteke et al.The prevalence of CVD was 75.2% (C0s-C6), which is very
high. This result does, however, include patients with a C0s
level. This may be disputable as some of the symptoms
could be the result of non-CVD disorders. Symptoms such as
night cramps, restless legs, and heavy legs are not always
caused by venous disease. Very often, it is not possible to
make a distinction between the cause of these symptoms
(C0s) especially in a GP practice, without performing any
additional examinations such as duplex-ultrasound. Hence
considering C0s patients with a limited number of symp-
toms as suffering from CVD, leads to an overestimation of
measured CVD prevalence. The percentage of C1-C6 pa-
tients in this survey was 61.3%, which is comparable to15,19
or higher16,18 than the percentages from similar surveys in
other countries. In those surveys where the percentage of
C1-C6 patients was lower, the mean age of patients was
lower as well.
This survey measured the prevalence of CVD in a popu-
lation visiting a GP. This population does not exactlyFigure 4. Correlation between rrepresent the average population in Belgium and
Luxembourg. The mean age (53.4 years) of the study pop-
ulation is higher than the mean for the Belgian population
(40.35 years, economie.fgov.be). The female predominance
(67.5%) is also higher. These differences inﬂuence the
measured prevalence of CVD.
In this survey CVD was measured using the C-classiﬁca-
tion (only the C from CEAP). This classiﬁcation is commonly
used in clinical practice. However, the reproducibility of this
C-classiﬁcation is moderate,22 especially if used by GPs who
are not in the habit of working with it.
When GPs were asked whether the patient being exam-
ined had CVD, a positive answer was given in 45.9% of
cases, but the prevalence of CVD in Belgium and
Luxembourg (including the C0s to the C6 patients) is 75.2%.
Such discrepancy can be explained as most of the GPs do
not consider C0s and C1 patients to be patients with dis-
ease. Only 7.8% and 40.5% of the C0s and C1 patients,
respectively, were considered by their GPs to have a CVD,egular exercise and C-class.
Figure 5. Correlation between family history and C-class.
Chronic Venous Disease in Belgium and Luxembourg 437with actual ﬁgures raised to more than 80% from C2 and up
to 94.3% at C5 (sample size at C6 is too small for compar-
ison). The interpretation of such results is that it is not until
patients have varicose veins (C2) that GPs consider they
have a CVD. In other words, they do not consider early
stages of CVD (i.e. C0s and C1) as part of the disease.
The GPs referred 11% of the patients to a vein specialist,
while 6.5% were already under specialist care. This referral
was related to a higher C-class. Probably, GPs are not always
convinced that patients having a lower C-class need to be
referred to a specialist. They might believe that they can
help those patients with conservative treatment. In 49.5%
of patients, a treatment was proposed: lifestyle advice
(78.6%), venoactive drug (69.3%), compression therapy
(42.2%), and anticoagulation therapy (14.1%).
A signiﬁcant correlation was found between age and
severity of CVD. This relationship is upheld by manyFigure 6. Correlation betweepidemiological studies,1,3 and is most likely the result of
increased pressure on superﬁcial veins caused by weak-
ening of calf muscles coupled with the gradual deterioration
of vessel walls over time.3
Although the prevalence of varicose veins is usually re-
ported to be greater in women,3,23e25 results in relation to
CVI have been inconsistent. Some studies have shown the
prevalence of CVI to be higher in men,2,23,26 whereas others
have reported a higher prevalence in women27,28 or no
difference at all.16 The present study found that female
patients had a signiﬁcantly higher C-class compared with
men. There was also a signiﬁcant correlation between the
number of pregnancies and the severity of CVD (in all age
groups). Although not consistent,28 pregnancy is presumed
to be a major contributory factor in the increased incidence
of varicose veins in women.29 Pregnancy is associated with
a number of physiological changes, which probablyen smoking and C-class.
Table 3. C-classiﬁcation versus mean number of symptoms
currently present in total population.
C-classiﬁcation Mean number of symptoms
C0s 1.9  1.2
C1 1.5  1.5
C2 2.3  1.7
C3 3.3  1.5
C4 3.9  1.9
C5 4.5  1.9
C6 4.1  2.3
p <.0001
438 M.E. Vuylsteke et al.contribute to the development of venous distention and
potentially to varicose veins. There is a signiﬁcant increase
in blood volume, which is primarily caused by plasma vol-
ume expansion.3 In addition, fetal growth and weight gain
increase intra-abdominal pressure and impair venous re-
turn.30,31 Hormonal changes, such as an increase in relaxin
and progesterone levels, will also weaken the blood vessel
wall and have a vasodilator effect.31 This will increase the
pressure on the venous valves in the lower limbs.
Risk factors such as obesity32 (increased intra-abdominal
pressure) and lack of regular exercise (decreased calf pump
function) increase the venous pressure and thus impair the
venous ﬂow. These arguments are supported by the present
ﬁndings, as a positive signiﬁcant correlation was noted
between BMI, absence of regular exercise, and the severity
of CVD (with the exception of males in the 18e34 year age
group).
The most common risk factor was a family history of CVD.
Of all the patients examined, 55.2% had a positive family
history, particularly relating to the mother (mother only in
65.1% of patients with a positive history). This raises a
question about the heritability of CVD. The heritability of
CVD is high, which suggests a notable genetic component in
the etiology of the disease.28,33 This conclusion, however,
should be interpreted with care, as these results are from a
questionnaire. As in many other reports, this survey relies
on self reported family history without validation by clinical
examination of family members.
Smoking (currently or in the past) is considered a possible
risk factor for varicose veins.8 However, a positive correla-
tion could be found only in males between the ages of 35
and 65 years old. The present data did not reveal any
relationship between smoking and the severity of CVI in
females.Table 4. Short-CIVIQ Global Index Score versus C-class in total
population.
C-classiﬁcation Short-CIVIQ Global Index Score
C0s 87.91  14.00
C1 89.22  12.87
C2 83.09  15.23
C3 72.70  16.66
C4 66.10  20.88
C5 58.37  22.37
C6 55.56  29.96
p <.0001In the present survey 64.7% of all enrolled patients had
at least one symptom. The most common symptoms were
heavy legs (in 45.6% of symptomatic patients), pain in the
legs (34.9%), sensation of swelling (34.1%) and night cramps
(30.1%). A positive correlation was found between the
number of symptoms and the C-class (Table 3). Patients
with a higher average C-class (C3-C6) on average have more
symptoms. A negative correlation was found between the
C-class and quality of life (GIS, Table 4). This proves that
patients with symptoms of varicose veins have an impaired
QoL. QoL decreases from the very ﬁrst symptoms of CVD
and with the cumulative number of symptoms. The QoL
impairment is linked to the severity of CVD (C-
classiﬁcation).
In 2013 39,607 (www.inami.fgov.be) vascular in-
terventions were performed for venous disease in Belgium
(total population of 11,099,554). Surgical procedures for
varicose veins are among the most frequently performed
interventions. In this survey, in the patient group with
diagnosed CVD, 10.4% had time off work because of venous
disease. In that group, 17.2% lost working time of more
than 1 month. This resulted in an important number of days
of incapacity to work. It was noted that 0.9% of all the
patients had a C6-classiﬁcation. Venous ulcers are painful34
and difﬁcult to treat. In a population study in the UK, the
median duration of ulceration was 9 months, 20% of ulcers
had not healed within 2 years, and 66% of patients had
episodes of ulcerations lasting longer than 5 years.35 Their
treatment imposes important costs and signiﬁcantly impairs
quality of life. The impact of CVD on public health budgets is
considerable. Treatment of venous incompetence can aid
healing and prevent the recurrence of ulcers.36,37 It there-
fore seems reasonable to speculate that such treatments
could reduce the risk of ulcers if performed early in the
course of CVD.38
CONCLUSION
CVD is a very common and underestimated disease. Its
prevalence increases with age. This study found that female
patients had a signiﬁcantly higher C-class compared with
men. There is an association between BMI, absence of
regular exercise, number of pregnancies, a positive family
history, and the severity of CVD. QoL decreases from the
very ﬁrst symptoms of CVD and with the cumulative num-
ber of symptoms. CVD generates incapacity to work and
worsens patients’ quality of life.
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